Lebwohl, M.; Stein Gold, L.; Gooderham, M.; Papp, K.; Ferris, L.; Adam, D.; Hong, H. C.- ho; Kircik, L.; Zirwas, M.; Burnett, P.; Higham, R.; Krupa, D.; Berk, D. Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. J of Skin 2023, 7, s111.